A neuroscience biotech company focused on transforming the treatment landscape for CNS disorders.
EQUULUS Therapeutics is a leading biotechnology research company dedicated to transforming the treatment landscape for central nervous system (CNS) disorders. Focusing on psychiatric, neurologic, and addiction disorders, EQUULUS Therapeutics leverages the expertise of a highly accomplished team drawn from academia, biotech, and pharmaceutical sectors.
Driven by innovation and precision, EQUULUS Therapeutics employs a transdiagnostic approach to therapeutic development, targeting fundamental factors that transcend standard diagnostic categories. By focusing on key criteria and the underlying mechanisms of CNS disorders, EQUULUS Therapeutics aims to address the crucial origins of disease. The company is also actively developing and applying biomarkers to enhance drug development success rates, ensuring the creation of highly valued therapeutics.
EQUULUS Therapeutics is committed to maximizing drug efficacy and product value through expertise in novel drug formulations and delivery approaches. Visit www.equulus.com to learn more about how EQUULUS Therapeutics is pioneering new solutions in biotechnology research. To the manager of EQUULUS Therapeutics, we invite you to create a customized and exclusive company showcase and product listing on our platform.
Compare EQUULUS Therapeutics with 3 companies in Biotechnology-Research
| Comparison Field |
EQUULUS TherapeuticsMain Company |
DebiopharmView Profile |
KeylikaView Profile |
HemostODView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1979 | 2022 | 2020 |
|
Company Size
|
— | 201-500 | 2-10 | 2-10 |
|
City
|
Walnut Creek, CA | |||
|
Country
|
United States | |||
|
Skills & Keywords
Comparing with main company
|
13 Total Skills
Biotechnology
CNS Disorders
Drug Development
Neurology
Psychiatry
Addiction Treatment
Biomarkers
serotonin
transdiagnostic
neuroscience
Addiction
drug development
drug delivery
|
6 Total
6 Unique
Unique Skills:
antimicrobials
Biopharmaceutical
digital health
Healthcare
oncology
Science & innovation
|
9 Total
9 Unique
Unique Skills:
Bioinorganic drugs
first principles design
formulation
IDA
Iron deficiency anemia
organometallic drugs
+3
|
26 Total
26 Unique
Unique Skills:
allogenic therapy
alloimmunization
biodrug
bioengineering
biologics
biopharma
+20
|
Other organizations in the same industry
This company is also known as